TRIB (Trinity Biotech) Float Percentage Of Total Shares Outstanding: 97.55% (As of Jun. 29, 2026)


TRIB Trinity Biotech PLC TRIB
25 GF Score
Price $0.42
GF Value $0.73
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Trinity Biotech Float Percentage Of Total Shares Outstanding?

Trinity Biotech TRIB +17.06% 25 Float Percentage Of Total Shares Outstanding is 97.55% as of Jun. 29, 2026. GuruFocus rates TRIB with a GF Score™ of 25/100 and a GF Value™ of $0.73 (Possible Value Trap). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Trinity Biotech's float shares is 19.75 Mil. Trinity Biotech's total shares outstanding is 20.25 Mil. Trinity Biotech's float percentage of total shares outstanding is 97.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Trinity Biotech's Insider Ownership is 2.33%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Trinity Biotech's Institutional Ownership is 5.30%.

TRIB
25GF Score
Trinity Biotech PLC TRIB
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trinity Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Trinity Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=19.75/20.25
=97.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 97.55% mean?
Trinity Biotech (TRIB) has a Float Percentage Of Total Shares Outstanding of 97.55% as of Jun. 29, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Trinity Biotech and its competitors.
Is Trinity Biotech's Float Percentage Of Total Shares Outstanding too high?
Trinity Biotech's current Float Percentage Of Total Shares Outstanding is 97.55%. Overall, Trinity Biotech has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trinity Biotech's Float Percentage Of Total Shares Outstanding compare to AIDX and NVNO?
Trinity Biotech's Float Percentage Of Total Shares Outstanding of 97.55% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Trinity Biotech and its competitors. Trinity Biotech's current Float Percentage Of Total Shares Outstanding is 97.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trinity Biotech stock overvalued right now?
Based on GuruFocus' analysis, Trinity Biotech (TRIB) is currently considered Possible Value Trap. The stock's GF Value™ is $0.73, compared to a current price of $0.42 — trading 42.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 97.55%. Trinity Biotech's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Trinity Biotech (TRIB), the current Float Percentage Of Total Shares Outstanding is 97.55% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trinity Biotech (TRIB) Overvalued in 2026?

Based on GuruFocus' analysis, Trinity Biotech stock appears to be undervalued. The current stock price of $0.42 is trading 42.8% below its estimated GF Value™ of $0.73. GuruFocus considers Trinity Biotech to be Possible Value Trap.

Key valuation signals for TRIB:

  • Float Percentage Of Total Shares Outstanding: 97.55%
  • GF Value™: $0.73 vs. price of $0.42 (42.8% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the TRIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trinity Biotech Business Description

Address IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
25GF Score

Get the complete analysis for TRIB

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.73
GF Value